AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $91.52, giving the company a market capitalization of 283.79B. It carries a P/E multiple of 29.98 and pays a dividend yield of 1.7%.
On 2025-11-24, AstraZeneca(AZN) stock traded between a low of $90.51 and a high of $91.83. Shares are currently priced at $91.52, which is +1.1% above the low and -0.3% below the high.
AstraZeneca(AZN) shares are trading with a volume of 5.72M, against a daily average of 5.49M.
During the past year, AstraZeneca(AZN) stock moved between $61.24 at its lowest and $91.91 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $61.24 at its lowest and $91.91 at its peak.
AZN News
Hong Kong-based Harbour BioMed announced on Sunday an update and advancement of its global strategic collaboration with AstraZeneca Plc (NASDAQ:AZN) , initially...
TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to Tip...
Harbour BioMed announced an update and advancement of its global strategic collaboration with AstraZeneca (AZN), originally established in March 2025. The colla...
Analyst ratings
81%
of 31 ratingsMore AZN News
TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to Tip...
(RTTNews) - AstraZeneca announced plans to invest $2 billion to expand its long-standing manufacturing presence in Maryland. The investment includes a major exp...
...
Key Points The pharmaceutical giant is plowing billions of dollars into expanding its drug-making capacity. It has ambitious plans for two facilities in Maryl...
AstraZeneca (AZN) on Friday announced plans to invest $2B in Maryland to boost its U.S. production capacity with a sizable expansion of an existing biologics fa...
On Thursday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Koselugo (selumetinib) for adult patients with neurofibromatosi...
A lot can happen for this quantum computing leader over the next decade. Ten years go by quickly. Duke University professors Chris Monroe and Jungang Kim found...
